Micro Medical Solutions closes equity financing, raising $3.6 million

Wilmington, MA December 15, 2015—Interventional pioneer Micro Medical Solutions announces the closing on its latest round of funding, bringing total raised from equity financings to date to approximately $3.6 million. The funding will be used for further development and clinical trials for its Below the Knee (BTK) stent delivery platform. CEO Gregory Sullivan commented that “this equity financing allows us to bolster our research and development, quality assurance testing, and regulatory approval processes for our first-in-class technology as we move toward 510K and CE Mark approval for several of our innovative minimally invasive products in 2016.” Micro Medical Solutions plans for the launch of its Micro Vascular Integrated Platform (mVIP) in 2017 for the treatment of peripheral artery disease (PAD)/critical limb ischemia (CLI) lesions BTK, and prevention of amputations due to CLI.

CONTACT: Peg Thornton, Director of Corporate and Market Development, Micro Medical Solutions 732-616-9123

About CLI

Peripheral artery disease (PAD) and critical limb ischemia (CLI) affected 215 million people worldwide in 2015, predicted to be 230 million by 2020.1 CLI currently afflicts 2.8 to 3.5 million of those with PAD and is projected to rise to 4.5 to 5.6 million.2 Rates of amputations in the general population with PAD are declining, but amputations in CLI continue to escalate. It has been estimated that 25% of CLI patients will undergo major amputation. Prognosis with respect to limb preservation in CLI patients is poor, particularly in no-option CLI patients, where six-month major amputation rates have been reported to be as high as 50%.3 If something doesn’t change, the number of amputations due to CLI could exceed one million by 2030.

References: 1. Global Peripheral Artery Disease Market: Trends & Opportunities (2015-2020), February 2016 (Page 19). Daedal Research Group. 2. Critical Limb Ischemia. Volume 1 United States Epidemiology, 2010. Accessed at[orts/cliepiusreprot.php., October 14, 2016. 3. Teraa M, Conte MS, Moll FL, Verhaar MC. Contemporary Reviews: Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc 2016; 5: e002938.

Back To Top